Search Results - "Biological agent"

Aviation medicine capacity on facing biological threat In Indonesia airports by Yuli Subiakto

Connect to this object online.

Biologically Hazardous Agents at Work and Efforts to Protect Workers' Health: A Review of Recent Reports by Kyung-Taek Rim, Cheol-Hong Lim

Connect to this object online.

Psoriasis, biologic therapy, and the pandemic of the 21st century by Miguel Nogueira, Ron Vender, Tiago Torres

Connect to this object online.

Effects of TNF antagonists on immune and neuroendocrine system by M. Cutolo, G. Valesini

Connect to this object online.

The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab by Sara Ghoneim, Alvaro J. Ramos-Rodriguez, Fernando Vazquez de Lara, Lauren Bonomo

Connect to this object online.

The economic burden of TNFα inhibitors and other biologic treatments in Norway by Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al

Connect to this object online.

Side effects of anti-TNFa therapy in juvenile idiopathic arthritis by Elisabetta Valcamonica, Barbara Teruzzi, Gabriele De Marco, Alessandra Salmaso, Alfredomaria Lurati, Maurizio Gattinara, Valeria Gerloni, Irene Pontikaki, Flavio Fantini

Connect to this object online.

Bacterial and fungal aerosols in the work environment of cleaners by Małgorzata Gołofit-Szymczak, Rafał L. Górny, Anna Ławniczek-Wałczyk, Marcin Cyprowski, Agata Stobnicka

Connect to this object online.

Sarcopenia assessed by computed tomography or magnetic resonance imaging is associated with the loss of response to biologic therapies in adult patients with Crohn's disease by Jingjing Liu, Hongye Tang, Tingting Lin, Jiangchuan Wang, Wenjing Cui, Chao Xie, Zhongqiu Wang, Yugen Chen, Xiao Chen

Connect to this object online.

Biologics in the management of psoriasis by Jennifer D Bahner, Lauren Y Cao, Neil J Korman

Connect to this object online.

A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagoni... by Leonardi Craig L, George Mary, Hurley M Yadira, Frater John L

Connect to this object online.

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease by Cristián Navarrete-Dechent, Daniela Majerson, Marisa Torres, Daniela Armijo, Mahir Patel, Alan Menter, Claudia de la Cruz

Connect to this object online.

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis by Zhou Q, Zhou S, Xiong H, Yang J, Yang Z, Zhou N, Mao J, Li M

Connect to this object online.

The Ulcerative colitis - ustekinumab as a new biologic therapy, review 2024 by Zuzanna Felińska, Julia Silldorff, Tomasz Fura, Marcin Dudek, Radosław Zaucha, Oliwia Iszczuk, Stanisław Anczyk, Magdalena Gajkiewicz, Małgorzata Zając

Connect to this object online.

Progress in immune pathogenesis and targeted therapy of alopecia areata by Jiali WANG, Dantong CHENG, Nana LUO, Pingsheng HAO

Connect to this object online.

New perspectives on the treatment of hidradenitis suppurativa by Victoria Amat-Samaranch, Eugènia Agut-Busquet, Eva Vilarrasa, Lluís Puig

Connect to this object online.

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa by Elisa Molinelli, Claudia Sapigni, Giovanni Marco D'Agostino, Valerio Brisigotti, Giulio Rizzetto, Ivan Bobyr, Oscar Cirioni, Andrea Giacometti, Lucia Brescini, Sara Mazzanti, Annamaria Offidani, Oriana Simonetti

Connect to this object online.

The cost of biologics for psoriasis is increasing by Judy Cheng, Steven R Feldman

Connect to this object online.

Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma by Han MA, Shu Qiu, Rongbiao Lu, Peiying Feng, Chun Lu

Connect to this object online.

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability by Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J

Connect to this object online.